Fri, Mar 29, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Andera Partners raises its largest life sciences fund at $443m

Tuesday, October 11, 2022

Laxman Pai, Opalesque Asia:

Andera Life Sciences, the business line specializing in innovative therapeutics and medical technologies Venture capitalist Andera Partners, has raised €456m ($443m) for its biggest-ever life sciences fund.

According to a press release from the player in private company investments in France and internationally, the sixth generation of BioDiscovery funds (BioDiscovery 6 fund) is consolidating Andera Partners' position as one of the leading players in life sciences venture capital in Europe.

Existing institutional investors include funds of funds, insurance companies, pension funds, family offices, private investors, and pharmaceutical companies, it said.

The Andera Life Sciences partners (Sofia Ioannidou, Olivier Litzka, Gilles Nobecourt, Jan Van den Bossche, Raphael Wisniewski) said: "We are honored by the support of our investors which is strengthening our position as one of the main players in our sector. The acceleration of our funds' development demonstrates investors' growing interest in financing medical innovation. For over twenty years, Andera Life Sciences' support for companies has resulted in over twenty treatments being made available to patients and their doctors. This is the work that we wish to continue."

"The new fund will enable the management team to pursue its investment strategy focused on building a balanced portfolio of innovative companies developing therapeutics and medical technologies, at all stages of......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1